Envestnet Portfolio Solutions
GMAB icon

Envestnet Portfolio Solutions’s Genmab GMAB Stock Holding History

Envestnet Portfolio Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,592
Closed -$388K – 1377
2025
Q4 		$388K Sell
12,592
-723
-5% -$22.5K ﹤0.01% 1158
2025
Q3 		$408K Buy
13,315
+1,657
+14% +$40.4K ﹤0.01% 1106
2025
Q2 		$241K Sell
11,658
-2,353
-17% -$48.3K ﹤0.01% 1434
2025
Q1 		$274K Sell
14,011
-6,066
-30% -$127K ﹤0.01% 1338
2024
Q4 		$419K Sell
20,077
-8,330
-29% -$183K ﹤0.01% 1326
2024
Q3 		$693K Buy
28,407
+2,595
+10% +$69.4K ﹤0.01% 1046
2024
Q2 		$649K Sell
25,812
-1,943
-7% -$55.1K ﹤0.01% 1026
2024
Q1 		$830K Buy
27,755
+633
+2% +$18.6K ﹤0.01% 910
2023
Q4 		$864K Buy
27,122
+6,681
+33% +$210K ﹤0.01% 834
2023
Q3 		$721K Buy
+20,441
New +$779K ﹤0.01% 844

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Envestnet Portfolio Solutions's GMAB Position: Q1 2026 in Review

Envestnet Portfolio Solutions sold out of Genmab (GMAB) in Q1 2026, closing a stake of 12,592 shares — an estimated $388K sold.

Envestnet Portfolio Solutions first reported a position in GMAB in Q3 2023 and held it in 10 quarters. The position peaked at $864K in Q4 2023. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Envestnet Portfolio Solutions reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 12,592 Genmab shares in Q1 2026, an estimated $388K.
  • Envestnet Portfolio Solutions first reported a position in Genmab in Q3 2023 and held it in 10 quarters.
  • Envestnet Portfolio Solutions's Genmab position peaked at $864K in Q4 2023.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.